Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

TAK-003 was efficacious against symptomatic dengue in countries in which the disease is endemic. (Funded by Takeda Vaccines; TIDES ClinicalTrials.gov number, NCT02747927.).